BRNS vs NFLX · $38.2M cap vs P/E 25, rev $12.56B
Barinthus Biotherapeutics plc (BRNS) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
BRNS currently screens at market cap $38.2M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the BRNS and NFLX stock pages for the full models.
Not investment advice.